Modulating the Internalization of Bacille Calmette-Guérin by Cathelicidin in Bladder Cancer Cells-Reference-Cited by-同舟云学术

Modulating the Internalization of Bacille Calmette-Guérin by Cathelicidin in Bladder Cancer Cells

Published:2015-04 Issue:4 Volume:85 Page:964.e7-964.e12
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Choi Se Young,Kim Soon-Ja,Chi Byung Hoon,Kwon Jong Kyou,Chang In Ho^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference13 articles.

1. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002

2. Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guerin (BCG) in bladder cancer cells;Kim;BJU Int,2013

3. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection;Chromek;Nat Med,2006

4. Human antimicrobial peptides LL-37 and human beta-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus;Crack;Clin Exp Dermatol,2012

5. Cathelicidin LL-37: a multitask antimicrobial peptide;Bucki;Arch Immunol Ther Exp(Warsz),2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCG and Autoimmunity;Infection and Autoimmunity;2024

2. Unexpected Transient Glioblastoma Regression in a Patient Previously Treated with Bacillus Calmette–Guérin Therapy: A Case Report and Immunomodulatory Effects Hypothesis;Journal of Personalized Medicine;2023-11-28

3. Enhanced Antitumor Effect of the Combination of Bacille Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder Cancer-On-a-Chip;BioChip Journal;2023-10-17

4. Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model;Investigative and Clinical Urology;2023

5. Immunotherapeutic effects of recombinant Bacillus Calmette–Guérin containing sic gene in ex vivo and in vivo bladder cancer models;Investigative and Clinical Urology;2022